After CEO pleads guilty, Indivior inks $600M deal to escape opioid marketing accusations

After CEO pleads guilty, Indivior inks $600M deal to escape opioid marketing accusations

Source: 
Fierce Pharma
snippet: 

The federal government's yearslong probe into sales of opioid addiction therapy Suboxone Film has turned out some eye-popping plea deals in recent months. Now, weeks after its former CEO pleaded guilty to federal charges, Suboxone maker Indivior has inked a hefty settlement of its own to stay out of court.